Among patients with chronic insomnia, transcutaneous auricular vagus nerve stimulation improves sleep quality and is safe and effective.

Reports of anaphylaxis associated with the use of glatiramer acetate have prompted the Food and Drug Administration (FDA) to add a Boxed Warning to the prescribing information.

A total of 62.7% of patients expressed the desire to be notified about the use of artificial intelligence (AI) in patient care.

The FDA has approved the sBLA for once every 4 weeks lecanemab-irmb (Leqembi®) intravenous maintenance dosing.

COVID-19 was associated with more severe disease outcomes than influenza or respiratory syncytial virus (RSV) during the 2022 to 2023 season.

The US Centers for Disease Control and Prevention (CDC) has taken down multiple health-related websites and datasets, including those on HIV, LGBTQ health and more, following executive orders from the ...

The US Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin.

HealthDay News — Many very preterm infants experience pain, according to a study published online Jan. 21 in Pain. Hillary Graham, from the Karolinska Institutet in Stockholm, and colleagues explored ...

For patients with obstructive sleep apnea (OSA), sleep surgery is associated with a significantly reduced risk for motor vehicle accidents (MVA) compared with continuous positive airway pressure (CPAP ...

For people with diabetes, the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a reduced risk for certain disorders and conditions.

In an extended follow-up study, intensive blood pressure control is associated with reductions in the rate of cognitive impairment.

Referral to a specialized, comprehensive functional seizures treatment clinic is linked to reduced health care costs and utilization.